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PreviewsThe  versus 
T Cell Fate Decision:
When Less Is More
How does signaling through receptors with very sim-
ilar signaling pathways promote distinct cell fates?
For the  versus  T cell fate, quantitative differ-
ences in T cell antigen receptor signaling appear to
be crucial (Hayes et al., 2005; Haks et al., 2005; this
issue of Immunity).
Since the surprising discovery that T cells use two very
different types of clonally variable antigen receptors,
termed αβTCR and γδTCR, the mechanism by which
developing T cells decide to become αβ- or γδ-express-
ing T cells has been a subject of considerable interest.
Early thymocyte progenitors (CD4−CD8−, double nega-
tive, or DN) can give rise to either αβ or γδ lineage T
cells, and the antigen receptors themselves are thought
to play a key role in this process, either by directing the
fate of uncommitted precursors, promoting the matura-
tion of committed T cells, or both (Kang et al., 2001;
Robey and Fowlkes, 1998; von Boehmer et al., 1998).
The antigen receptors in question are the γδTCR, com-
posed of variable γ and δ chains, and the pre-TCR,
composed of the variable β chain and invariant preTα
chain (Figure 1). Although many of the signaling com-
ponents used by the γδTCR and the pre-TCR are similar,
there are indications that the pre-TCR may deliver
weaker signals than the γδTCR. Based on these obser-
vations, a quantitative model for αβ versus γδ lineage
commitment has been proposed in which early thymo-
cytes that express γδTCR receive strong signals that
promote the γδ T cell fate and those that express pre-
TCR receive weaker signals that promote the αβ T cell
fate (Hayes et al., 2003).
Two reports in this issue of Immunity provide compel-
ling evidence for this quantitative model for αβ versus
γδ lineage commitment. The experimental systems are
based on mice bearing rearranged γδTCR transgenes
that can give rise not only to γδ T cells but also to αβ
lineage T cells (as defined by expression of CD4, CD8,
TCRα germline transcripts, and repression of γδTCR ex-
pression). Both groups showed that they could alter the
numbers of γδ and αβ lineage cells produced by manip-
ulating the signal strength at numerous points in the
signal transduction cascade (Figure 1). These manipu-
lations included alterations in surface γδTCR levels, the
number of signaling motifs, the amount of receptor-
associated tyrosine kinase Lck, the level of the down-
stream transcription factor Egr, the level of the negative
regulator CD5, and removal of a ligand for the γδTCR.
In every case, manipulations designed to reduce signal
strength produced more αβ lineage cells, whereas
those that increased signaling favored γδ lineage devel-
opment. Importantly, both groups also showed thatFigure 1. TCR Signal Strength and the αβ versus γδ T Cell Fate
Decision
Early thymocyte precursors (CD4−CD8−, double negative, or DN)
rearrange their TCR β, γ, and δ genes and, depending on the out-
come of rearrangement, may express either a γδTCR (top) or a pre-
TCR composed of β TCR and an invariant preTα chain (middle).
Expression of a γδTCR leads to a strong TCR signal, high levels of
ERK phosphorylation, strong induction of the Egr family of tran-
scription factors, and ultimately promotes the γδ T cell fate. Expres-
sion of the pre-TCR leads to a weaker TCR signal, moderate phos-
phorylation of ERK and Egr induction, and ultimately promotes the
αβ T cell fate. Experimental manipulations that reduce γδTCR sig-
naling in the thymus (bottom, indicated by an “x”) promote the αβ
fate at the expense of γδ development.precursor thymocytes that express γδTCR have higher
levels of signaling intermediates compared to those ex-
pressing the pre-TCR. Together these data make a
strong case for a quantitative signaling model for αβ
versus γδ T cell fate determination.
These studies raise a number of interesting ques-
tions. Why does the γδTCR produce stronger signals
than the pre-TCR? A clue may be found in the observa-
tion that the cell surface levels of pre-TCR are much
lower than those of the γδTCR. Although extracellular
ligands for the γδTCR and the pre-TCR have not been
well defined, one possibility is that ligand-induced trig-
gering is involved in γδTCR, but not pre-TCR, signaling.
Although the role of ligands in γδT cell development re-
mains controversial (Schweighoffer and Fowlkes, 1996),
the observation that a γδTCR ligand can promote γδ T
cell development at the expense of αβ T cell develop-
ment (Haks et al., 2005) provides an indication that li-
gand induced signaling may be involved, at least for
certain γδTCRs. What is the mechanism by which signal
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